Evidence-based medication adherence in hispanic patients with systolic heart failure in a disease management program

Kathy Hebert, Julieta Beltran, Leonardo Tamariz, Elyse Julian, Andre Dias, Pat Trahan, Lee Arcement

Research output: Contribution to journalArticle

5 Scopus citations


The Hispanic population is the fastest growing minority in the United States, yet there is a paucity of data regarding patient follow-up in heart failure disease management programs (HFDMPs) and evidence-based medication adherence. The purpose of this study is to measure the compliance of evidence-based medication use, specifically measuring angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and β-blockers (BBs) in the Hispanic population, and compare these data to the white and black population. The authors conducted a cross-sectional study of 561 patients enrolled in an HFDMP at Jackson Medical Hospital in Miami, Florida. At the first visit, 82% of Hispanic, 75% of white, and 79% of black patients were taking ACEIs/ARBs, but only 21% of Hispanic, 35% of white, and 32% of black patients were taking target doses. Hispanic patients are as compliant with ACEI/ARB and BB regimens as are the white and black populations in HFDMPs in a setting of similar socioeconomic features.

Original languageEnglish (US)
Pages (from-to)175-180
Number of pages6
JournalCongestive Heart Failure
Issue number4
StatePublished - Jul 1 2010


ASJC Scopus subject areas

  • Emergency Medicine
  • Emergency
  • Cardiology and Cardiovascular Medicine

Cite this